E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Towa...( LEXINGTON Ky. July 7 /- VirtualHe...),Health

LEXINGTON, Ky., July 7 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM) the nation's only proven Real-Time Prescription Monitoring System announced it's support today of a proposed rule that would allow for the electronic prescribing of controlled substances.

June 27th, the Drug Enforcement Administration proposed regulations that would allow physicians to electronically prescribe controlled substances. Current rules bar e-prescriptions for controlled substances, classified as medications that have the potential for abuse or addiction. Controlled substances account for between 10% and 13% of all U.S. prescriptions. The DEA hopes to reduce prescription forgery by creating a "closed system of controls on controlled-substances dispensing." In a separate initiative the House recently approved a bill (HR 6331) that would provide an incentive to physicians to use e-prescribing that would sharply increase its adoption.

According to Jim Renfro, President of VHGI, "Both of these recent events are very exciting for Veriscrip because they are key factors in facilitating the use of e-prescribing in real-time Prescription Drug Monitoring. From the beginning our company has stressed the importance of tracking controlled substances from their inception electronically." Renfro goes on further to say, "I am confident that once these rules are put into effect, you will begin to see more local and state governments moving more aggressively to curtail the misuse and major abuse of prescription drugs in a real time manner. I think we have positioned Veriscrip to be a leader in this effort and to take full advantage of the potential new business, which will result from this rule change."

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject
'/>"/>